Severity Categorization for Pharmaceutical Evaluation (SCOPE) Criteria of Quintana-Barcena et al for Drug-Related Problems (DRP)

Description

Quintana-Barcena et al reported the Severity Categorization for Pharmaceutical Evaluation (SCOPE). This describes the severity of a drug-related problem (DRP) and how a pharmacist responds to it. The authors are from Universite de Montreal, Cenre de Sante et de Services Sociaux de Laval and Centre de Recherche du Centre Hospitalier.

Patient selection: chronic kidney disease

Level	Category of DRP	Pharmacist
I	mild	prevents a problem by modifying drug regimen
II	mild	resolves a problem; start therapy for minor condition with known diagnosis and therapy
III	moderate	as for II, plus starts diagnostic follow-up
IV	moderate	as for III, plus tells patient to see physician as soon as possible
V	severe	tells patient to see physician or go to ED immediately
VI	severe	calls 911 and for immediate medical assistance

The pharmacist communicates actions to the treating physician or clinic.

To read more or access our algorithms and calculators, please log in or register.

Severity Categorization for Pharmaceutical Evaluation (SCOPE) Criteria of Quintana-Barcena et al for Drug-Related Problems (DRP)

Description

Specialty